Your browser doesn't support javascript.
loading
A peripherally restricted P2Y12 receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonism.
Brott, David A; Andersson, Håkan A S; Stewart, Jane; Ewart, Lorna; Christoph, Greg; Harleman, Johannes; Armstrong, Duncan; Kinter, Lewis B.
Afiliação
  • Brott DA; Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, R&D, Wilmington, DE, USA.
  • Andersson HAS; Drug Safety & Metabolism, AstraZeneca, R&D, Södertälje, Sweden.
  • Stewart J; Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, R&D, Alderley Park, UK.
  • Ewart L; Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, R&D, Alderley Park, UK.
  • Christoph G; Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, R&D, Wilmington, DE, USA.
  • Harleman J; Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, R&D, Alderley Park, UK.
  • Armstrong D; Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, R&D, Alderley Park, UK.
  • Kinter LB; Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, R&D, Wilmington, DE, USA.
Toxicol Rep ; 1: 1202-1212, 2014.
Article em En | MEDLINE | ID: mdl-28962330

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Toxicol Rep Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Toxicol Rep Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos